93 related articles for article (PubMed ID: 38596689)
21. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
22. Single-cell dissection reveals the role of aggrephagy patterns in tumor microenvironment components aiding predicting prognosis and immunotherapy on lung adenocarcinoma.
Sun X; Meng F; Nong M; Fang H; Lu C; Wang Y; Zhang P
Aging (Albany NY); 2023 Dec; 15(23):14333-14371. PubMed ID: 38095634
[TBL] [Abstract][Full Text] [Related]
23. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
[TBL] [Abstract][Full Text] [Related]
24. Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma.
Tang L; Chen Z; Yang J; Li Q; Wang S; Mo T; Zeng W; Ding H; Pan S
Front Immunol; 2024; 15():1352893. PubMed ID: 38390340
[TBL] [Abstract][Full Text] [Related]
25. Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma.
Fan T; Lu J; Niu D; Zhang Y; Wang B; Zhang B; Zhang Z; He X; Peng N; Li B; Fang H; Gong Z; Zhang L
Front Immunol; 2022; 13():1046121. PubMed ID: 36483553
[TBL] [Abstract][Full Text] [Related]
26. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.
Green AC; Marttila P; Kiweler N; Chalkiadaki C; Wiita E; Cookson V; Lesur A; Eiden K; Bernardin F; Vallin KSA; Borhade S; Long M; Ghahe EK; Jiménez-Alonso JJ; Jemth AS; Loseva O; Mortusewicz O; Meyers M; Viry E; Johansson AI; Hodek O; Homan E; Bonagas N; Ramos L; Sandberg L; Frödin M; Moussay E; Slipicevic A; Letellier E; Paggetti J; Sørensen CS; Helleday T; Henriksson M; Meiser J
Nat Metab; 2023 Apr; 5(4):642-659. PubMed ID: 37012496
[TBL] [Abstract][Full Text] [Related]
27. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
[TBL] [Abstract][Full Text] [Related]
28. GALNT2 sustains glioma stem cells by promoting CD44 expression.
Liu Y; Chen P; Xu L; Wang B; Zhang S; Wang X
Aging (Albany NY); 2023 Mar; 15(6):2208-2220. PubMed ID: 37000153
[TBL] [Abstract][Full Text] [Related]
29. NK cells are never alone: crosstalk and communication in tumour microenvironments.
Zhou Y; Cheng L; Liu L; Li X
Mol Cancer; 2023 Feb; 22(1):34. PubMed ID: 36797782
[TBL] [Abstract][Full Text] [Related]
30. GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.
Liao YY; Chuang YT; Lin HY; Lin NY; Hsu TW; Hsieh SC; Chen ST; Hung JS; Yang HJ; Liang JT; Huang MC; Huang J
Mol Oncol; 2023 Jan; 17(1):119-133. PubMed ID: 36409270
[TBL] [Abstract][Full Text] [Related]
31. Hippo Signaling Pathway Regulates Cancer Cell-Intrinsic MHC-II Expression.
Zeng Z; Gu SS; Ouardaoui N; Tymm C; Yang L; Wong CJ; Li D; Zhang W; Wang X; Weirather JL; Rodig SJ; Hodi FS; Brown M; Liu XS
Cancer Immunol Res; 2022 Dec; 10(12):1559-1569. PubMed ID: 36219700
[TBL] [Abstract][Full Text] [Related]
32. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
[TBL] [Abstract][Full Text] [Related]
33. The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer.
Hu Q; Tian T; Leng Y; Tang Y; Chen S; Lv Y; Liang J; Liu Y; Liu T; Shen L; Dong X
Cell Mol Biol Lett; 2022 Sep; 27(1):71. PubMed ID: 36058918
[TBL] [Abstract][Full Text] [Related]
34. Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets.
Shao H; Ge M; Zhang J; Zhao T; Zhang S
BMC Cancer; 2022 Mar; 22(1):288. PubMed ID: 35300639
[TBL] [Abstract][Full Text] [Related]
35. Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma.
Wang Y; Li X; Peng S; Hu H; Wang Y; Shao M; Feng G; Liu Y; Bai Y
Front Cell Dev Biol; 2021; 9():638374. PubMed ID: 34513820
[TBL] [Abstract][Full Text] [Related]
36. An immunogenomic signature for molecular classification in hepatocellular carcinoma.
Zhuang W; Sun H; Zhang S; Zhou Y; Weng W; Wu B; Ye T; Huang W; Lin Z; Shi L; Shi K
Mol Ther Nucleic Acids; 2021 Sep; 25():105-115. PubMed ID: 34401208
[TBL] [Abstract][Full Text] [Related]
37. One carbon metabolism in human lung cancer.
Yao S; Peng L; Elakad O; Küffer S; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Ströbel P; Bohnenberger H
Transl Lung Cancer Res; 2021 Jun; 10(6):2523-2538. PubMed ID: 34295659
[TBL] [Abstract][Full Text] [Related]
38. Inference and analysis of cell-cell communication using CellChat.
Jin S; Guerrero-Juarez CF; Zhang L; Chang I; Ramos R; Kuan CH; Myung P; Plikus MV; Nie Q
Nat Commun; 2021 Feb; 12(1):1088. PubMed ID: 33597522
[TBL] [Abstract][Full Text] [Related]
39. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells.
Cheng S; Li Z; Gao R; Xing B; Gao Y; Yang Y; Qin S; Zhang L; Ouyang H; Du P; Jiang L; Zhang B; Yang Y; Wang X; Ren X; Bei JX; Hu X; Bu Z; Ji J; Zhang Z
Cell; 2021 Feb; 184(3):792-809.e23. PubMed ID: 33545035
[TBL] [Abstract][Full Text] [Related]
40. Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer.
Zhang S; Iyer S; Ran H; Dolgalev I; Gu S; Wei W; Foster CJR; Loomis CA; Olvera N; Dao F; Levine DA; Weinberg RA; Neel BG
Cancer Discov; 2021 Feb; 11(2):362-383. PubMed ID: 33158842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
